Aripiprazole Lauroxil
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Case Series: Simultaneous Use of Long-Acting Injectable Antipsychotics and Vivitrol or Long-Acting Buprenorphine in Dual Diagnosis Patients with Bipolar Disorder and Substance Use Disorders.
Journal: Psychopharmacology bulletin
Published: March 13, 2026
Impact of macrophages on the dissolution of LAI suspension prodrugs.
Journal: International journal of pharmaceutics
Published: January 11, 2026
Perimenopause as an obesogenic sensitive period: Contributions to elevated cardiovascular risk.
Journal: American journal of preventive cardiology
Published: November 22, 2025
Mechanistic Modeling of Intramuscular Administration of a Long-acting Injectable Accounting for Tissue Response At the Depot Site.
Journal: The AAPS journal
Published: July 28, 2025
Aripiprazole Lauroxil Every 2 Months for the Treatment of Adults With Schizophrenia: A Post Hoc Analysis of Efficacy by Baseline Severity of Illness From Phase 3b Clinical Trial Data.
Journal: Schizophrenia bulletin open
Published: June 09, 2025
Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: April 22, 2025
Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen in Patients with Schizophrenia.
Journal: Advances in therapy
Published: February 27, 2025
Aripiprazole Lauroxil Every 2 Months or Paliperidone Palmitate Monthly for Acute Schizophrenia: A Post Hoc Analysis of PANSS Five-Factor Scores in the ALPINE Trial.
Journal: Neuropsychiatric disease and treatment
Published: December 05, 2024
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: October 16, 2024
Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders.
Journal: Journal of child and adolescent psychopharmacology
Published: August 24, 2024
Initiating Aripiprazole Lauroxil: Post Hoc Analysis of Safety and Tolerability of 1-Day and 21-Day Regimens.
Journal: The Journal of clinical psychiatry
Published: August 15, 2024
A 16-Year-Old Male with Autism Spectrum Disorder, Psychosis, and Refusal to Accept Any Oral Medication: A Case Report and Use of Long-Acting Injectable Aripiprazole Lauroxil.
Journal: Journal of child and adolescent psychopharmacology
Published: July 24, 2024
Last Updated: 04/28/2026